Roche Diagnostics disclosed CVE-2025-7674 in navify Monitoring before 1.08.00, base score 7.1. An API lacks adequate input validation, so crafted or excessive user-supplied data can be processed unsafely and cause a denial of service.
A denial of service through unvalidated input rarely requires sophistication. Where software assumes that incoming data will be well-formed and sized within reason, a request that violates those assumptions can exhaust memory, stall a thread, or drive processing down an error path that never returns. The flaw is one of misplaced trust; the code treats the far end of the connection as cooperative, and an attacker simply declines to cooperate.
For a monitoring platform the availability of the service is the service. Its purpose is to be watching when a condition changes, so an outage removes exactly the oversight the operators were counting on it to provide. A disruption that keeps the platform down, even briefly, is a gap in visibility rather than a mere inconvenience, and the timing of that gap belongs to the attacker.
Credit where due: Roche publishes a real product security advisory page in a field where plenty of peers publish nothing, and disclosing your own bug with a CVE and a fixed version is the behavior the industry claims to want. Input validation on an API is the baseline, and also the thing that gets skipped under deadline. Validate at the boundary, cap the sizes, reject the malformed request before it reaches anything that matters.
Self-disclosure of this kind reflects a maturing corner of the sector. When a manufacturer runs its own assessments, records what it finds, and posts the results, the information reaches the hospitals running the software instead of circulating first among attackers. That discipline remains uneven across medical devices, and its absence elsewhere is what makes each published advisory notable rather than routine.